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NF-KB and the other members of the Rel family of tran- 
scriptional activator proteins have been a focal point for 
understanding how extracellular signals induce the ex- 
pression of specific sets of genes in higher eukaryotes. 
Unlike most transcriptional activators, this family of pro- 
teins resides in the cytoplasm and must therefore translo- 
cate into the nucleus to function. The nuclear translocation 
of Rel proteins is induced by an extraordinarily arge num- 
ber of agents ranging from bacterial and viral pathogens 
to immune and inflammatory cytokines to a variety of 
agents that damage cells. Remarkably, an even larger 
number of genes appear to be targets for the activation 
by Rel proteins. As a result of these properties, we are 
confronted with two intriguing questions: how do multiple 
signal transduction pathways lead to the activation of NF- 
KB, and how does a particular inducer lead to the activa- 
tion of only one or a subset of the genes targeted by NF- 
KB? Answers to these questions require a detailed 
understanding of the pathways of Rel protein activation 
and the mechanisms by which the genes targeted by Rel 
proteins are turned on. Here, we review recent progress 
in understanding the mechanisms involved in the activa- 
tion of NF-KB, the function of individual Rel family proteins, 
and synergistic interactions between Rel proteins and 
other families of transcription factors, leading to specific 
gene activation. 
The Rel and IKB Families 
The Rel protein family has been divided into two groups 
based on differences in their structures, functions, and 
modes of synthesis (Baeuerle and Henkel, 1994; Sieben- 
list et al., 1994). The first group consists of p50 (NF-KB1) 
and p52 (NF-KB2), which are synthesized as precursor 
proteins of 105 and 100 kDa, respectively. The mature 
proteins, which are generated by proteolytic processing, 
have a so-called Rel homology domain that includes DNA- 
binding and dimerization domains and a nuclear localiza- 
tion signal. The mature proteins form functional Rel dimers 
with other members of the family, while dimers containing 
the unprocessed proteins remain sequestered in the cyto- 
plasm. The second group of Rel proteins, which includes 
p65 (RelA), Rel (c-Rel), RelB, and the Drosophila Rel pro- 
teins dorsal and Dif, are not synthesized as precursors. 
In addition to the Rel homology domain, they possess one 
or more transcriptional activation domains. Members of 
both groups of Rel proteins can form homo- or heterodim- 
ers; e.g., NF-KB is a p50-p65 heterodimer. 
Two types of Rel protein complexes are found in the 
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Figure 1. Hypothetical Pathway for NF-~<B Activation 
Any one of several extracellular inducers activates one or more signal 
transduction pathways leading to the activation of a protein kinase(s) 
that phosphorylates IKB and p105. This phosphorylation can be 
blocked by alkylating agents or antioxidants. Phosphorylated IKB and 
p105 are then recognized by ubiquitin-cenjugating e zymes (this has 
been shown for p105, but not yet for I~:B). Ubiquitinated IKB and p105 
are then degraded and processed, respectively, to produce active 
NF-KB, which translocates to the nucleus. Both degradation and pro- 
cessing are blocked by proteasome inhibitors. Nuclear NF-KB then 
synergizes with other t anscriptional activators andwith HMG I(Y) to 
form a higher order (stereospecific) enhancer complex. The example 
shown is the IFNI3 gene promoter, which is activated exclusively by 
virus infection and not by any of the other NF-KB inducers. Abbrevia- 
tions not defined in text: IRF, IFN-regulatory factor; PMA, phorbol my- 
ristate acetate; Ub, ubiquitin; UV, ultraviolet light. 
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cytoplasm prior to induction. The first type consists of Rel 
homo- or heterodimers (e.g., p50 and p65) bound to a 
member of the IKB family of inhibitor proteins (IKB-(~, 
IKB-13, IKB-y, and Bcl-3 and the Drosophila protein cactus). 
Members of this family share a characteristic ankyrin re- 
peat motif that is required for their interactions with Rel 
proteins and a C-terminal PEST sequence thought to be 
involved in protein degradation (Beg and Baldwin, 1993). 
The second type of complex consists of a heterodimer 
formed between a mature Rel protein (e.g., p65) and an 
unprocessed Rel protein precursor (e.g., p105). An induc- 
ing signal leads to the phosph0rylation of both IKB and 
p105 (Beg and Baldwin, 1993; Mellits et al., 1993; Nau- 
mann and Scheidereit 1994). This phosphorylation is 
thought to be the signal for IKB degradation and p105 
processing, both of which generate active Rel dimeric 
complexes that translocate to the nucleus and activate 
genes containing Rel protein-binding sites (KB sites) 
(Baeuerle and Henkel, 1994; Siebenlist et al., 1994). 
Multiple Signal Transduction Pathways 
In mammals several different signal transduction path- 
ways have been implicated in NF-KB activation, all of 
which culminate in the phosphorylation of IKB. Unfortu- 
nately, none of the pathways has been fully elucidated, 
and a so-called IKB kinase has yet to be definitively identi- 
fied (Siebenlist et al., 1994). Activation of N F-K B by double- 
stranded RNA requires the double-stranded RNA-depen- 
dent protein kinase (Maran et al., 1994), while activation 
by tumor necrosis factor a (TN F~) does not. Both the sphin- 
gomylenase/ceramide and Raf pathways have been impli- 
cated in TNF(~ induction of NF-KB (for discussion see Sie- 
benlist et al., 1994), and induction of NF-KB by anti-CD28 
antibodies in T cells involves the rapamycin-sensitive p70 
$6 kinase pathway (Lai and Tan, 1994). 
Common steps in all of these pathways are suggested 
by the observation that certain inhibitors like antioxidants 
(Baeuerle and Henkel, 1994) and alkylating agents 
(Henkel et al., 1993; Mellits et al., 1993; Finco et al., 1994) 
inhibit the phosphorylation and subsequent degradation 
of IKB-(~. Thus, the target of these inhibitors could be an 
IKB kinase. A critical question is whether all of the NF-KB 
signal transduction pathways lead to the activation of a 
common IKB kinase or whether distinct kinases are acti- 
vated by different pathways. A candidate for an IKB kinase 
(pelle) was recently identified in Drosophila (Wasserman, 
1993). The pelle kinase requires the presence of another 
protein (tube) for its in vivo function, and both proteins 
specifically interact (GroBhans et al., 1994). Although the 
target for pelle has not been identified, it may be cactus, 
dorsal, or both. 
Distinct Properties of IKB.a and I•B.# 
IKB-(x was cloned and characterized several years ago 
(Beg and Baldwin, 1993), but IKB-13 (Zabel and Baeuerle, 
1990) has long eluded capture. The recent cloning of a 
cDNA encoding h<B-13 led to the discovery of yet another 
mechanism for controlling the activation of Rel proteins 
(Thompson et al., 1995 [this issue of Cell]). Although h<B-~ 
interacts with the same spectrum of Rel protein dimers 
as h<B-(z, the two proteins display distinct responses to 
different NF-~:B inducers. Degradation of IKB-a occurs 
with all of the NF-KB inducers tested, while IK B-13 responds 
to only a subset. For example, treatment of cells with TNF(~ 
or phorbol myristate acetate causes a transient activation 
of NF-KB and the transient loss of IKB-(~. The transient 
response is due to the fact that NF-KB up-regulates the 
expression of IKB-(~. Thus, newly synthesized IKB-(~ resets 
the NF-KB switch in the cytoplasm. By contrast, induction 
with interleukin-1 (IL-1) or lipopolysaccharide (LPS) results 
in degradation of both IKB-(~ and IKB-13, and the activity 
of NF-KB persists for several hours following stimulation, 
despite the presence of newly synthesized IKB-(~ (Thomp- 
son et al., 1995). The failure to observe the reappearance 
of IKB-I~ under these circumstances uggests that, unlike 
IKB-a, IKB-13 is not up-regulated by NF-~B. Thus, the con- 
tinued expression of NF-KB in the absence IKB-13 may 
create an imbalance in the relative levels of IKB and NF- 
KB, leading to the persistent expression of the genes in- 
duced by IL-1 and LPS. These results have two interesting 
implications. First, there must be more than one I•B ki- 
nase, or the inactivation of IKB-13 requires a different mech- 
anism. Second, differences in the regulation of IKB-a. and 
IKB-13 gene expression can lead to differences in the timing 
and level of expression of genes targeted by NF-KB. 
Mechanisms of NF.KB Activation 
Until recently, it was thought hat phosphorylation induced 
the dissociation of IKB from the ternary complex with NF- 
KB, and free IKB was then constitutively degraded. How- 
ever, the recent finding that the ubiquitin-proteasome 
pathway is involved in the activation of Rel protein com- 
plexes has provided a very different picture (see Figure 
1). In vitro studies demonstrated that ubiquitination of p105 
is a prerequisite for in vitro processing and that the ubiqui- 
nated p105 is processed by purified proteasomes (Palom- 
bella et al., 1994). In addition, proteasome inhibitors block 
p105 processing both in vitro and in vivo. Although ubiqUiti- 
nation of IKB-(~ has not yet been demonstrated, protea- 
some inhibitors also block IKB-a degradation and NF-KB 
activation (Palombella et al., 1994; Traenckner et al., 
1994). Significantly, in the presence of these inhibitors, 
phosphorylated IKB-e. iS not degraded after TNF(~ irld~U(: - 
tion and remains bound to NF-KB (Palombella et al., 1994; 
Traenckner et al., 1994; Finco et al., 1994; Miyamoto et 
al., 1994; Lin et al., 1995). Thus, I~:B phosphorylation may 
be the signal for protein degradation rather than dissocia- 
tion from NF-KB. 
Distinct Functions for pSO and RelB 
Genes encoding p50 and RelB have recently been inacti- 
vated by targeted gene disruption in mice (Sha et al., 1995; 
Weih et al., 1995). These studies dramatically demon- 
strate distinct functions for different members of the rel 
gene family. Mice lacking p50 or RelB develop normally 
to adulthood with no obvious morphological defects. Thus, 
neither gene is essential for development, but, as for many 
members of multigene families, their normal functions may 
be provided by another family member. In spite of this 
problem, it is clear that a number of critical functions of 
p50 and RelB in adults are not redundant. Although mice 
lacking p50 have normal levels of B cells that display nor- 
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mal levels of K light immunoglobuiin chain gene expres- 
sion, they show abnormalities in mitogenic activation of 
B cells and specific antibody production (Sha et al., 1995). 
For example, LPS fails to induce NF-KB proteins or to 
promote B cell differentiation in cells lacking p50. By con- 
trast, anti-immunoglobulin M antibody induces both NF- 
KB proteins and B cell proliferation in these cells. Thus, 
LPS and anti-immunoglobulin M antibodies must activate 
distinct signal transduction pathways. These observations 
further underscore the complex and divergent signal trans- 
duction pathways used by the same cell to respond to 
different stimuli. The absence of the p50 subunit of NF-KB 
dramatically decreases the ability of mice to resist certain 
bacterial infections, but actually leads to an increase in 
the level of interferon-J3 (IFN~) gene expression induced 
by virus. Although NF-KB (p50-p65) is thought to be the 
Rel dimer involved in IFNI~ gene expression in normal cells 
(Thanos and Maniatis, 1995), other Rel family members 
(e.g., virus-inducible p65 homodimers) may substitute for 
the loss of p50 in knockout mice. Overexpression of the 
IFN~ gene could be a consequence of this Rel family 
switch, since the level of expression may ordinarily be 
modulated by p50-dependent repression (see below). 
The inactivation of the relB gene in mice further rein- 
forces the notion that different Re proteins play distinct 
biological roles. Although the p50 and p65 subunits of 
NF-KB are widely expressed in virtually every cell type, 
RelB is preferentially expressed in lymphoid tissues, and 
its level of expression peaks by day 10 after birth. Mice 
devoid of the relB gene develop normally to day 8-10, but 
subsequently display a complex pathological phenotype 
resulting from multiple defects in the adult immune system 
(Weih et al., 1995). 
Taken together, the p50 and relB knockout studies es- 
tablish a striking difference in the requirements of p50 
and RelB. The p50-containing complexes, presumably the 
p50-p65 heterodimer, function as rapid mediators of the 
acute inflammatory and immune responses. By contrast, 
the constitutive nuclear presence of RelB in lymphoid cells 
activates the expression of genes required for the develop- 
ment and homeostasis of the immune system after birth. 
Other members of the Rel family may be able to compen- 
sate for the loss of at least some of the functions of either 
p50 or RelB. Thus, the inactivation of relA and other mem- 
bers of the rel gene family and the examination of double 
knockouts should be informative. 
This division of labor of Rel family members in the mouse 
parallels that observed in Drosophila, where the dorsal 
protein is required for dorsal-ventral patterning of the early 
embryo and where the related Dif protein is expressed 
specifically in the fat body, where it is involved in the activa- 
tion of primitive immune response genes that are activated 
in response to bacterial infection (Ip and Levine, 1994). 
Rel Dimers Preferentially Interact with Distinct 
KB.Binding Sites 
At least part of the gene-specific activity of Rel proteins 
is a consequence of differences in the DNA recognition 
properties of different homo- and heterodimers. Rel family 
proteins bind to their recognition sequences as dimers 
with an unusually high affinity compared with most eukary- 
otic activators (e.g., the p50-p65 heterodimer binds to a 
typical KB site with a KD of - 10-12 mol/I). With the excep- 
tion of RelB, every member of the mammalian Rel family 
can form homo- or heterodimers with each other. RelB 
does not form homodimers, but it can heterodimerize with 
p50 or p52 (Siebenlist et al., 1994; Baeuerle and Henkel, 
1994). Depending on the cell type or the activation state 
of a given cell, different homo- and heterodimers can be 
found in the nucleus or in the cytoplasm. Moreover, each 
combination of Rel protein preferentially binds to a particu- 
lar subset of KB-binding site sequences. Thus, different 
Rel dimeric complexes can be directed to promoters 
based on the presence of specific KB-binding sites. 
High Mobility Group-like Proteins as Coactivators 
and Corepressors of NF.KB 
Rel proteins are subject to further levels of control subse- 
quent to their release from h< B proteins and their transloca- 
tion into the nucleus. For example, virus induction of the 
human IFNI3 gene requires NF-KB, which binds to a spe- 
cific KB site (GGGAAATTCC) in the IFN[3 promoter. How- 
ever, NF-KB is not sufficient for activation from this site. 
The high mobility group protein HMG I(Y) is also required 
for transcriptional activation (Thanos and Maniatis, 1992). 
NF-KB recognizes the GC-rich bases at the ends of this 
KB site through contacts in the major groove of the DNA 
helix, while HMG I(Y) binds to the AT-rich center through 
contacts in the minor groove. HMG I(Y) stimulates the 
binding of NF-KB to the IFNJ3 promoter and specifically 
interacts with the p50 and p65 subunits. Thus, HMG I(Y) 
functions as a promoter-specific coactivator of NF-KB 
(Thanos and Maniatis, 1992). 
An HMG-like protein can also function as a corepressor 
of NF-KB. This finding grew out of studies showing that 
the Drosophila dorsal protein can function as an activator 
on one gene and a repressor on another within the same 
cell type (for a recent review, see Ip, 1995). The promoters 
of both types of genes contain multiple dorsal-binding 
sites, but the repressed gene contains additional se- 
quences required for dorsal-dependent repression. Re- 
cently, a Drosophila protein called dorsal switch protein 
1 (DSP1) was shown to convert both dorsal and NF-KB 
from activators to repressors in mammalian cells (Lehming 
et al., 1994). The repression activity of DSP1 requires the 
presence of a negative regulatory element near the KB- 
binding site. Remarkably, an identical negative regulatory 
element is present in the ventral repression element of 
the Drosophila zen gene and in a negative regulatory ele- 
ment of the human IFN~ gene. DSP1 was shown to act 
on both of these regulatory sequences in mammalian co- 
transfection experiments (Lehming et al., 1994). DSP1 re- 
pression of the human IFNl5 promoter requires the pres- 
ence of p50, either as a homodimer or as a heterodimer 
with p65. As mentioned above, the loss of p50-dependent 
DSP1 repression may explain whythe IFNJ3 gene is overin- 
duced in p50 knockout mice. DSP1 contains two HMG 
boxes, which constitute a DNA-binding domain first identi- 
fied in the HMG proteins 1 and 2. A mammalian DSP1 
protein has yet to be identified, but is likely to exist, consid- 
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ering the sequence identity of the negative regulatory ele- 
ment in Drosophila and humans and given the ability of 
Drosophila DSP1 to act on mammalian Rel family proteins. 
Interfamily Cooperativity and Combinatorial 
Mechanisms 
The specificity of gene activation achieved through intra- 
Rel family interactions is significantly expanded by struc- 
tural and functional interactions between Rel family pro- 
teins and members of other families of transcriptional 
activators (for review see Siebenlist et al., 1994). NF-KB 
has been shown to synergize with a number of different 
transcriptional activator proteins, including Spl ,  Ets, 
ATF-2/c-Jun, and NF-IL6, to name a few. This synergy is 
a consequence of direct interactions between NF-KB and 
these proteins and cooperative binding to adjacent binding 
sites. The interacting transcription factors can be present 
constitutively or coinduced with NF-KB. An excellent ex- 
ample of the latter is the recent demonstration that several 
inducers of NF-KB activate the c-Jun N-terminal protein 
kinase (JNK), which in turn phosphorylates ATF-2 and 
c-Jun, both of which synergize with NF-KB (Gupta et al., 
1995). In the case of the human IFNI3 gene promoter, this 
synergy appears to result from the assembly of a higher 
order protein-DNA complex comprised of at least three 
distinct transcriptional activator proteins and the structural 
protein HMG I(Y). The assembly of this complex requires 
a precise arrangement of the binding sites on the face of 
the DNA helix and on multiple protein-protein interactions 
(see Tjian and Maniatis, 1994). The activation of E-selectin 
gene expression by TNF(~ in endothelial cells may occur 
by a very similar mechanism (Lewis et al., 1994; Meacock 
et al., 1994; Whitley et al., 1994). 
In summary, the activation of specific sets of genes in 
response to a given inducer begins with activation of one 
or more signal transduction pathways that converge on 
the phosphorylation of one or more IKB proteins, leading to 
their degradation and the translocation of a complex array 
of Rel dimers into the nucleus. The correct gene is selected 
for expression by virtue of the organization of its regulatory 
sequences and the presence of synergizing transcrip- 
tional activator proteins that are coinduced with NF-KB. 
There are many details to be filled in at each step of this 
process, and further surprises are certain. Continuing 
studies of the Rel family will likely lead to a general under- 
standing of the complex circuitry required for specific gene 
activation by extracellular signals in higher eukaryotes. 
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